男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Latest

Eli Lilly promotes new drug at CIIE

By SHI JING in Shanghai | chinadaily.com.cn | Updated: 2019-11-09 09:43
Share
Share - WeChat

Indianapolis-headquartered pharmaceutical company Eli Lilly and Company attended the second China International Import Expo with its latest medicine Taltz to moderate severe plaque psoriasis.

During the news conference on Thursday, a total of 17 Chinese domestic pharmaceutical companies signed intention agreements with Eli Lilly for the purchase of Taltz. The medicine has been approved by China's National Products Administration in September.

Eli Lilly and Company was not present at last year's CIIE. Julio Gay-Ger, president and general manager of Lilly China, said that they "were positively surprised by the huge success that CIIE had last year".

"So we really want to be part of the CIIE in the second year. We have had in the last 12 months five new molecular entities launched in China. This is very close to our record. More importantly, we have up to 40 new launches in the next seven to 10 years. We are bringing innovations to Chinese patients which will make a huge difference to them," he said.

Gay-Ger said the company has had expectations for Lilly China's sales and business growth.

"China is the second-largest pharmaceutical market in the world today. It is supposed to be the No 1 pharmaceutical market in the future. It is our top priority market and that is why we are investing so heavily and bringing so much innovation here," he said.

Lilly set up its Shanghai office in 1918, which was the first overseas office for the US pharmaceutical company. Lilly China's overall growth rate for the first half of 2019 exceeded 30 percent, reaching a record high throughout the company's 101-year history in China.

Ever since 2013, Lilly has invested about $320 million to build an insulin production facility in Suzhou. The site is set to be an integral part of Lilly's global supply chain, providing insulin products for China, Europe and other markets across the world in 2019.

"In the future, we can have new launches in China simultaneously or almost simultaneously with other markets in the world. That progress is in part because of the great reform that government is taking, which offers great opportunity to have all that happen," he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 开化县| 永春县| 铁岭县| 伊吾县| 阿拉善右旗| 军事| 佛山市| 迁西县| 化州市| 平凉市| 丹巴县| 杨浦区| 晋江市| 崇义县| 广昌县| 揭西县| 开封市| 湖州市| 北海市| 荆门市| 晋江市| 宜兰县| 隆化县| 西盟| 永济市| 胶州市| 桃源县| 阿城市| 泰来县| 平乡县| 宝鸡市| 靖远县| 新乡市| 奉新县| 朝阳区| 营山县| 蒲城县| 泗洪县| 巴南区| 农安县| 凤台县| 从化市| 石景山区| 丰县| 漳平市| 雷山县| 吴忠市| 扶绥县| 万安县| 东乌珠穆沁旗| 平度市| 三明市| 新平| 延津县| 红河县| 乌恰县| 长顺县| 保山市| 苏州市| 鸡西市| 甘洛县| 镇赉县| 宁乡县| 和田市| 高雄县| 合水县| 东平县| 长海县| 泽州县| 岳普湖县| 竹溪县| 斗六市| 霍邱县| 崇信县| 祁门县| 松阳县| 赣州市| 宿州市| 鄂伦春自治旗| 肥城市| 五原县| 太原市|